clinical trial · NCT07049913
TBE Zone 2 PMS in Japan
W.L.Gore & Associates·—·recruiting·n = 200
Aneurysm ThoracicDissection of Aorta, ThoracicTraumaGore® TAG® Thoracic Aortic Branch Stent Graft System
brief summary
The goal of this surveillance is to confirm the TBE device's safety and efficacy in patients treated with proximal landing in Zone 2 in the post-marketing period.
started
Dec 15, 2025
primary completion
Feb 1, 2034
completion
Feb 1, 2034
last updated
Feb 5, 2026
official title
GORE® TAG® Thoracic Branch Endoprosthesis Zone 2 Post-Market Surveillance in Japan
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol